AKT1 and breast carcinoma: In breast cancer, collagens and fibronectin secreted by cancer-associated fibroblasts in TME had been shown to induce multi-drug resistance by activating PI3K/AKT and Ras/Raf/MEK/ERK1-2 pathways [14].